Amedisys Inc (AMED)

Amedisys Inc's solvency ratios indicate a strong financial position with consistently low levels of debt relative to assets, capital, and equity over the years. The Debt-to-assets ratio, Debt-to-capital ratio, and Debt-to-equity ratio all stand at 0.00 for each year from 2020 to 2024, suggesting the company has no significant debt obligations compared to its total assets, capital, and equity.

Additionally, the Financial leverage ratio ranges from 1.88 to 1.99 over the same period, indicating that the company's assets are financed primarily through equity rather than debt. A lower financial leverage ratio is generally considered favorable as it signifies lower financial risk and a higher level of solvency.

Overall, based on the solvency ratios provided, Amedisys Inc appears to be in a solid financial position with minimal debt levels and a conservative capital structure, which may indicate a lower risk of financial distress and a higher ability to meet its financial obligations.

---

Coverage ratios

Amedisys Inc's interest coverage ratio shows the company's ability to meet its interest payment obligations. In 2020, the interest coverage ratio was 20.10, indicating that the company's operating income was more than sufficient to cover its interest expenses. The ratio increased to 30.42 in 2021, reflecting an improvement in the company's ability to cover interest costs.

However, there was a decrease in the interest coverage ratio to 8.21 in 2022 and further declined to 6.17 in 2023. These lower ratios suggest that Amedisys Inc's operating income may have become less sufficient to cover its interest expenses during those years.

By the end of 2024, the interest coverage ratio dropped to 1.80, signaling a significant decrease and a potential cause for concern. A ratio below 1 would indicate that the company's operating income is insufficient to cover its interest payments, which may raise questions about the company's financial health and ability to manage its debt obligations effectively.